Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma

British Journal of Haematology

Volumn 142, Issue 5, 2008, Pages 848-850

  De Lavallade, Hugues ^a   Cassier, Philippe A ^a   Bouabdallah, Reda ^a   El Cheikh, Jean ^a   Faucher, Catherine ^a   Fürst, Sabine ^a   Coso, Diane ^a   Sainty, Danielle ^a,b   Arnoulet, Christine ^a   Gastaut, Jean Albert ^a,b   Chetaille, Bruno ^a,b   Xerri, Luc ^a,b   Blaise, Didier ^a,b,c   Mohty, Mohamad ^a,b,c  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

Author keywords

Graft versus tumour effect; High grade lymphoma; Reduced intensity conditioning; T cell lymphoma

Indexed keywords

LEUKOCYTE ANTIGEN;

ALLOGENEIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; RECURRENT DISEASE; REDUCED INTENSITY CONDITIONING; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; RECURRENCE; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 48749130905     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07212.x     Document Type: Letter

References (8)

1. Armitage, J.O., Vose, J.M. Weisenburger, D.D. (2004) Towards understanding the peripheral T-cell lymphomas. Annals of Oncology, 15, 1447 1449.
2. van Besien, K.W., de Lima, M., Giralt, S.A., Moore, Jr., D.F., Khouri, I.F., Rondon, G., Mehra, R., Andersson, B.S., Dyer, C., Cleary, K., Przepiorka, D., Gajewski, J.L. Champlin, R.E. (1997) Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplantation, 19, 977 982.
3. Corradini, P., Dodero, A., Zallio, F., Caracciolo, D., Casini, M., Bregni, M., Narni, F., Patriarca, F., Boccadoro, M., Benedetti, F., Rambaldi, A., Gianni, A.M. Tarella, C. (2004) Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. Journal of Clinical Oncology, 22, 2172 2176.
4. Corradini, P., Dodero, A., Farina, L., Fanin, R., Patriarca, F., Miceli, R., Matteucci, P., Bregni, M., Scime, R., Narni, F., Pogliani, E., Locasciulli, A., Milani, R., Carniti, C., Bacigalupo, A., Rambaldi, A., Bonifazi, F., Olivieri, A., Gianni, A.M. Tarella, C. (2007) Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome. Leukemia, 21, 2316 2323.
5. Gallamini, A., Stelitano, C., Calvi, R., Bellei, M., Mattei, D., Vitolo, U., Morabito, F., Martelli, M., Brusamolino, E., Iannitto, E., Zaja, F., Cortelazzo, S., Rigacci, L., Devizzi, L., Todeschini, G., Santini, G., Brugiatelli, M. Federico, M. (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood, 103, 2474 2479.
6. Kim, S.W., Tanimoto, T.E., Hirabayashi, N., Goto, S., Kami, M., Yoshioka, S., Uchida, T., Kishi, K., Tanaka, Y., Kohno, A., Kasai, M., Higuchi, M., Kasai, M., Mori, S., Fukuda, T., Izutsu, K., Sao, H., Ishikawa, T., Ichinohe, T., Takeuchi, K., Tajima, K., Tanosaki, R., Harada, M., Taniguchi, S., Tobinai, K., Hotta, T. Takaue, Y. (2006) Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood, 108, 382 389.
7. Morris, E., Thomson, K., Craddock, C., Mahendra, P., Milligan, D., Cook, G., Smith, G.M., Parker, A., Schey, S., Chopra, R., Hatton, C., Tighe, J., Hunter, A., Peggs, K., Linch, D., Goldstone, A. Mackinnon, S. (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood, 104, 3865 3871.
8. Robinson, S.P., Goldstone, A.H., Mackinnon, S., Carella, A., Russell, N., de Elvira, C.R., Taghipour, G. Schmitz, N. (2002) Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood, 100, 4310 4316.